World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

EVALUATION OF THE PROGRAM FOR THE PREVENTION AND EARLY DETECTION OF CERVICAL CANCER IN CASTILLA Y LEÓN (SPAIN)

Marta Capilla Díez, Marta Domíngez-Gil, Angel San Miguel and Luis Inglada Galiana*

ABSTRACT

Cervical cancer screening is a check on the health of the cervix, the opening of the uterus into the vagina. And it helps prevent this cancer through the early detection of cellular abnormalities that can cause it. During screening, a small sample of cells is taken. These cells are tested for the human papillomavirus (HPV), which can cause abnormal cells in the cervix, and are visually examined for abnormalities. In Spain, the health system carries out cervical cancer screening for all women who have a cervix, between 25 and 65 years of age. Between the ages of 25 and 34, they undergo screening or cytology every 3 years, and between the ages of 35 and 65, a human papillomavirus (HPV) test is performed every 5 years.[2]

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR